Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jan 31:4:9.
doi: 10.21037/tbcr-23-3. eCollection 2023.

Advances of HER2 testing for women with breast cancer

Mamatha Chivukula  1
Affiliations
Editorial

Advances of HER2 testing for women with breast cancer

Mamatha Chivukula. Transl Breast Cancer Res. .
No abstract available

Keywords: Human epidermal growth factor receptor 2 (HER2); breast cancer; immunohistochemistry (IHC); in-situ hybridization (ISH); trastuzumab.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at https://tbcr.amegroups.com/article/view/10.21037/tbcr-23-3/coif). The author has no conflicts of interest to declare.

References

    1. Krishnamurti U, Silverman JF. HER2 in breast cancer: a review and update. Adv Anat Pathol 2014;21:100-7. 10.1097/PAP.0000000000000015 - DOI - PubMed
    1. Wang J, Xu B. Targeted therapeutic options and future perspectives for HER2-positive breast cancer. Signal Transduct Target Ther 2019;4:34. 10.1038/s41392-019-0069-2 - DOI - PMC - PubMed
    1. Nassar A, Pooja A, Chivukula M. HER2 testing across practices-Have we come to a consensus on the ideal method of testing? A systematic literature review. Breast J 2020;26:1185-8. 10.1111/tbj.13867 - DOI - PubMed
    1. Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007;25:118-45. 10.1200/JCO.2006.09.2775 - DOI - PubMed
    1. Wolff AC, Hammond ME, Hicks DG, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol 2013;31:3997-4013. 10.1200/JCO.2013.50.9984 - DOI - PubMed

Publication types